Clinical Trial Update: Cytarabine in Combination With Arsenic Trioxide vs. Cytarabine Alone in Elderly Patients With Acute Myeloid Leukemia [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing cytarabine with arsenic trioxide versus cytarabine alone in elderly patients with acute myeloid leukemia was terminated. Results were …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Arsenic Trioxide (arsenic trioxide)
• CYTARABINE (CYTARABINE)

Snippet

Sponsor: Cephalon | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: TERMINATED | Results posted: 2011-03-29